The cost of Onivyde (nal-IRI) varies depending on factors such as dosage, insurance coverage, and pharmacy. However, it is generally considered a high-cost medication. For instance, a single vial of Onivyde 50mg/mL can range from $1,200 to over $2,000 USD [1]. The price is often higher when considering the total treatment regimen, which may involve multiple vials.
How is Onivyde Covered by Insurance?
Insurance coverage for Onivyde can significantly impact out-of-pocket costs for patients. Many insurance plans require prior authorization before covering the drug. The specific co-pay or co-insurance amount will depend on the patient's individual insurance plan, including their deductible, co-pay tier, and annual out-of-pocket maximum [2]. Some manufacturers offer patient assistance programs that may help reduce out-of-pocket expenses for eligible individuals [2].
What Are Patient Assistance Programs for Onivyde?
Patient assistance programs aim to make expensive medications like Onivyde more accessible. These programs are often run by the pharmaceutical manufacturer or independent charitable organizations. They may provide financial assistance, co-pay cards, or free medication to eligible patients who meet certain income and insurance criteria [2]. Information regarding these programs is typically available through the drug's official website or by contacting the prescribing physician.
How Does Onivyde's Price Compare to Other Pancreatic Cancer Treatments?
Onivyde, a liposomal formulation of irinotecan, is used in combination therapy for metastatic pancreatic adenocarcinoma. Its cost is often comparable to other targeted therapies and chemotherapy agents used in oncology. The price of cancer medications is influenced by research and development costs, manufacturing complexity, clinical trial outcomes, and market demand [3]. For example, other advanced treatments for pancreatic cancer can also carry substantial price tags, making the overall cost of care a significant consideration for patients and healthcare systems.
When Does Onivyde's Patent Expire?
The patent expiry dates for Onivyde are crucial for understanding potential future market competition, such as the introduction of generic or biosimilar versions. DrugPatentWatch.com tracks patent information and can provide details on the exclusivity periods for specific drugs. Understanding patent timelines helps predict when the drug might become available at a lower cost [4].
Who Manufactures Onivyde?
Onivyde is manufactured by Ipsen Biopharmaceuticals [5]. Ipsen is a global specialty-driven biopharmaceutical group focused on innovative medicines.